KEY FEATURES
| Full Name | Lectin Like Oxidized Low Density Lipoprotein Receptor 1 |
|---|---|
| Synonym | OLR1; CLEC8A; SCARE1; Oxidized low-density lipoprotein receptor 1; C-type lectin domain family 8 member A; Lectin-like oxidized LDL receptor 1; Lectin-type oxidized LDL receptor 1 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human LOX1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human LOX1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human LOX1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human LOX1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human LOX1. You can calculate the concentration of Human LOX1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human LOX1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.49 | 1.51 | 4.52 | 0.51 | 1.54 | 4.63 |
| Standard deviation | 0.03 | 0.08 | 0.22 | 0.04 | 0.07 | 0.19 |
| CV(%) | 5.71 | 5.59 | 4.85 | 6.89 | 4.42 | 4.17 |
RECOVERY
The recovery of Human LOX1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 87-101 | 93 |
| EDTA plasma (n=8) | 94-106 | 99 |
| Cell culture media (n=8) | 91-107 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human LOX1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with OLR1 ELISA Kits
| CRP ELISA Kit | publications with OLR1 and CRP |
| NOS3 ELISA Kit | publications with OLR1 and NOS3 |
| CCL2 ELISA Kit | publications with OLR1 and CCL2 |
| APOB ELISA Kit | publications with OLR1 and APOB |
| ACE ELISA Kit | publications with OLR1 and ACE |
| VEGFA ELISA Kit | publications with OLR1 and VEGFA |
Pathways associated with OLR1 ELISA Kit
| Cell Surface Interactions At The Vascular Wall Pathway | Cell Surface Interactions At The Vascular Wall Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
| PPAR Signaling Pathway | PPAR Signaling Pathway |
| Phagosome Pathway | Phagosome Pathway |
Diseases associated with OLR1 ELISA Kit
| Cardiovascular Diseases | publications with OLR1 and Cardiovascular Diseases |
| Atherosclerosis | publications with OLR1 and Atherosclerosis |
| Heart Diseases | publications with OLR1 and Heart Diseases |
| Inflammation | publications with OLR1 and Inflammation |
| Coronary Disease | publications with OLR1 and Coronary Disease |
| Necrosis | publications with OLR1 and Necrosis |
| Hypertension | publications with OLR1 and Hypertension |
| Myocardial Infarction | publications with OLR1 and Myocardial Infarction |
| Dyslipidemias | publications with OLR1 and Dyslipidemias |
| Hyperlipidemias | publications with OLR1 and Hyperlipidemias |
Organs/Tissues associated with OLR1 ELISA Kit
| Blood | publications with OLR1 and Blood |
| Muscle | publications with OLR1 and Muscle |
| Brain | publications with OLR1 and Brain |
| Placenta | publications with OLR1 and Placenta |
| Liver | publications with OLR1 and Liver |
| Lung | publications with OLR1 and Lung |
| Kidney | publications with OLR1 and Kidney |
| Connective Tissue | publications with OLR1 and Connective Tissue |
| Intestine | publications with OLR1 and Intestine |
| Skin | publications with OLR1 and Skin |